800-680-7137Call For Help With Addiction
Talk To Someone Now
- Find a Clinic Near You
- Access Help and Resources
- Get 24-Hour Guidance and Information
SponsoredNo results found!
Finding opioid use disorder treatment in Boston
Boston is one of the better-resourced places in the country to start medication treatment for opioid use disorder (OUD). The city and Suffolk County are served by both opioid treatment programs (OTPs, the clinics that dispense methadone) and office-based providers who prescribe buprenorphine and naltrexone, many of them attached to major hospitals and community health centers. That density matters: it means most Boston residents have more than one medication and more than one setting within reach. The listings below show providers near you, and the site’s helpline can talk through a first step if you are not sure where to begin.
Your medication and setting options
Three medications are approved to treat OUD, and they are dispensed in two different kinds of settings. Understanding that split explains what the providers in the listings actually offer.
Methadone for OUD is provided only through a licensed opioid treatment program, not a regular pharmacy. You go to the OTP for dosing, daily at first, with take-home doses added as treatment stabilizes. Buprenorphine, including Suboxone and other buprenorphine-naloxone products, works differently: any clinician with a standard DEA registration can prescribe it in an office, and you fill it at a pharmacy. It also comes as a monthly extended-release injection (Sublocade). Buprenorphine is offered inside OTPs too. Naltrexone, including the monthly Vivitrol injection, is not a controlled substance and can be prescribed by any licensed provider, though treatment can only begin after you have been off opioids for a set number of days. If you want to think through which fits your life before you call, it helps to see how methadone and Suboxone compare and to read more about how methadone treatment works. This is a decision to make with a clinician; no single medication is right for everyone.
Starting treatment and what the first visit looks like
The first step is an intake assessment, where a provider reviews your history, current use, and health, then talks through medication options. Some Boston programs offer same-day or walk-in starts; ask when you call. One thing worth planning for: if you are using fentanyl, starting buprenorphine too soon can trigger sudden, severe withdrawal (called precipitated withdrawal), so a clinician will time your first dose carefully, sometimes using a low-dose start. This is manageable and routine, not a reason to wait. Methadone induction happens inside the OTP and does not carry the same timing risk. If most of your recent use has been fentanyl, it is worth reading about methadone treatment for fentanyl and reviewing your opioid treatment options before your visit.
Take-home doses, telehealth, and current rules
Federal rules updated in 2024 expanded take-home methadone (up to a 28-day supply for patients who are stable in treatment, on a graduated schedule), allowed treatment to start by telehealth, and removed older barriers to getting admitted, including the prior requirement of a one-year history of opioid use. Take-home eligibility is decided by your program based on your progress. As of July 2026, buprenorphine can be started through telehealth, including by phone in many cases, without a prior in-person visit; those flexibilities run through the end of 2026 and are still being finalized, so confirm current options with a provider. Methadone for OUD remains dispensed through an OTP, though some programs can begin treatment with a telehealth visit. These rules make transfers and returning to treatment easier than they were a few years ago, and long-term methadone treatment is legitimate, effective care. If you are moving your care, ask about guest dosing and why staying consistent with your dose matters during the switch.
Paying for treatment in Massachusetts
MassHealth, the state Medicaid program, covers all three medications for opioid use disorder. Behavioral health services, including OUD treatment, are managed through the Massachusetts Behavioral Health Partnership (MBHP), and the state Bureau of Substance Addiction Services (BSAS) oversees the treatment system. Since July 1, 2020, most MassHealth plans charge no copayment for substance use disorder treatment, including medications like Suboxone and Vivitrol. Private insurance and Medicare also cover MOUD, though specific plans vary in what they require, and some programs offer sliding-scale or self-pay options. If cost is your first concern, that is a normal place to start; a provider or the helpline can check your coverage before you commit to a program.
Overdose deaths are falling in Boston, and treatment is a big reason
Boston has seen a steep, sustained drop in fatal overdoses. The Boston Public Health Commission reported 120 opioid overdose deaths in 2025, the fewest in a decade, down 29 percent from 2024 and 56 percent from the 2023 peak of 272 deaths (Boston Public Health Commission, 2026). Fentanyl still drives most overdose risk, and researchers have noted xylazine increasingly mixed into the local drug supply, which naloxone does not reverse. The decline has not been shared equally: Black and Latinx residents made up about 37 percent of Boston’s population in 2025 but roughly 48 percent of overdose deaths. The reason to name these numbers is simple: they reflect what treatment and harm reduction can do, and effective, local opioid use disorder care is available across the city right now.
Naloxone, harm reduction, and staying safe while you decide
Naloxone, the medication that reverses an opioid overdose, is available in Massachusetts without a prescription. A statewide standing order has required pharmacies to dispense it since the end of 2017, and an over-the-counter Narcan product is also sold at pharmacies and retailers. Under Massachusetts law (M.G.L. c. 94C, § 19B, expanded by Chapter 208 of the Acts of 2018), anyone acting in good faith to give naloxone during an overdose is protected from criminal and civil liability. In Boston, the Public Health Commission’s AHOPE program provides syringe services, drug checking for fentanyl and xylazine, and naloxone; the PAATHS program connects people to detox, medication treatment, and outpatient care; and the Post Overdose Response Team follows up in person after 911 overdose calls. The city distributed nearly 35,000 doses of naloxone in 2025, its most ever. Keeping naloxone on hand is a practical safety step whether or not you are in treatment yet, and a return to use is a common, manageable part of recovery, not a failure. You can also read how to recognize and respond to an overdose.
Care for pregnancy and for people without stable housing
Two situations carry specific, high-stakes needs in Boston. For pregnant patients, methadone and buprenorphine are the recommended standard of care, and starting or staying in treatment protects both parent and infant; providers can also explain neonatal opioid withdrawal syndrome (NOWS) and how it is managed. Fear of child-welfare involvement keeps some people from seeking care, but treatment is what the guidance recommends, and a Plan of Safe Care is meant to support the family, not punish it. You can read more about methadone and pregnancy. For people who are unhoused, a population Boston’s outreach specifically targets, treatment does not require an address: hospital-linked clinics, community health centers, and street outreach teams can start medication and help with housing navigation. Families and loved ones trying to help can start with this guide for supporting someone in treatment.
Common questions about treatment in Boston
Do I have to go to a clinic every day?
Only methadone requires regular OTP visits, and even then, take-home doses (up to a 28-day supply for stable patients under the 2024 federal rules) reduce how often you go. Buprenorphine and naltrexone are prescribed in an office and filled at a pharmacy, so they do not involve daily clinic visits.
Can I start Suboxone by phone?
Often yes. As of 2026, buprenorphine can be started through telehealth, including audio-only in many cases, without a prior in-person visit. These flexibilities run through the end of 2026. Confirm current options with the provider you choose.
Is methadone available at a pharmacy in Boston?
No. Methadone for OUD is dispensed only through a licensed opioid treatment program, not a pharmacy. Buprenorphine and naltrexone are the medications you fill at a pharmacy. You can read what to expect at a methadone clinic.
What will it cost if I have MassHealth?
MassHealth covers all three OUD medications, and most plans have charged no copayment for substance use disorder treatment since July 2020. Coverage details can vary, so verify with your plan or ask the program during intake.
Is it bad to stay on medication long-term?
No. Long-term medication treatment is effective, evidence-based care, and staying on it is associated with lower overdose risk. Whether and when to taper is a decision to make with your clinician. You can read about when treatment might end.
Last reviewed and disclosures
Last reviewed July 2026.
Sources:
- Boston Public Health Commission, “New Data Show Fewest Opioid Overdose Deaths in Boston in a Decade,” 2026 (boston.gov)
- SAMHSA, “Medications for Opioid Use Disorder in Pharmacies” advisory, 2026 (library.samhsa.gov)
- SAMHSA, 42 CFR Part 8 final rule summary and MOUD overview, 2024 to 2026 (samhsa.gov)
- DEA and HHS, Fourth Temporary Extension of COVID-19 Telemedicine Flexibilities, 2025 to 2026 (federalregister.gov)
- Massachusetts General Laws c. 94C, § 19B, statewide naloxone standing order (malegislature.gov)
- Health Affairs, “Medicaid And Methadone For Opioid Use Disorder,” 2025 (healthaffairs.org)
Methadone Centers is a treatment-discovery and education resource, not a medical provider. Information here is educational and not a substitute for advice from a licensed clinician. No diagnosis, treatment recommendation, or outcome is guaranteed.
The helpline connected to this site is a sponsored, paid advertising resource. Calls may be answered by a participating treatment provider. Using it is not required to access any provider listed here.